That's one of the things that's a little frustrating. We just don't have the money or partnership to advance some of these indications like TBI/stroke, Fragile X, retts, Newman, APOE4 genetic issues, etc. I understand that could change in a heart beat and maybe it will sooner than later, but I hate to see some of this pushed back another year. The TBI studies that have been done with bryostatin are incredible.
That said, what a handful of employees/scientists are managing to do to slay this devastating disease with the money they do have is very impressive for those that follow.